/ RecruitingNot Applicable Registry for health care research and quality assurance in private oncological practices - ONCOReg
/ Not yet recruitingNot Applicable PHASE III, OPEN-LABEL, RANDOMIZED, MULTICENTER EFFICACY ANDSAFETY STUDY OF BENDAMUSTINE HYDROCHLORIDE VERSUSCHLORAMBUCIL IN TREATMENT-NAÏVE PATIENTS WITH (BINET STAGE B/C)B-CLL REQUIRING THERAPY
/ Unknown statusNot Applicable Phase III, Open-Label, Randomized, Multicenter Efficacy and Safety Study of Bendamustine Hydrochloride Versus Chlorambucil in Treatment-Nave Patients with (Binet Stage B/C) B-CLL Requiring Therapy
100 Clinical Results associated with ribosepharm GmbH
0 Patents (Medical) associated with ribosepharm GmbH
100 Deals associated with ribosepharm GmbH
100 Translational Medicine associated with ribosepharm GmbH